How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes – From Theory to Action

Author:

Oortwijn Wija,Sampietro-Colom Laura,Trowman Rebecca

Abstract

AbstractObjectivesReal-world evidence (RWE), derived from real-world data (RWD), is already used, to some extent, for health technology assessment (HTA) purposes. With the increased availability of RWD, there is potential for more widespread use but also challenges ensuring reliable RWE for HTA. Opportunities to overcome key challenges, identified at a scoping meeting, were discussed during the 2019 HTA international (HTAi) Global Policy Forum (GPF).MethodsReflection of discussions using Design Thinking (an interactive process aimed to solve complex problems) between seventy-three representatives from not-for-profit, for-profit organizations, and HTAi leadership. The discussions were informed by a background paper, and presentations from three invited keynote speakers and eleven GPF members.ResultsSeveral options were listed for addressing the identified key challenges: quality and acceptability, governance and accountability, transferability, and informing decision making. The GPF emphasized that the HTA community should first understand what questions could be answered with RWE. Additionally, more clarity on methods, standards, streamlining RWD collection, data sharing across jurisdictions, replication of RWD, and expert analysis were mentioned as important priorities.ConclusionsThe HTA community is currently standing at a cross-road as it is not yet fully equipped to address these key challenges. It is, therefore, time for action. The community should start aligning on what is the best source of evidence according to purpose and how the data should be collected to create reliable evidence. It should also initiate the development of actions and guidance to properly develop and manage RWD/RWE to inform decision making across the technology lifecycle.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy

Reference24 articles.

1. Patient-Centered Outcomes Research Institute (PCORI) (2019) PCORnet: The National Patient-Centered Clinical Research Network [website]. https://www.pcori.org/research-results/pcornet-national-patient-centered-clinical-research-network.

2. Murphy G , de Léséleuc L , Kaunelis D , (2018) Use of real-world evidence in single-drug assessments. Ottawa: CADTH, April 2018. (Environmental scan; no. 74). https://www.cadth.ca/use-real-world-evidence-single-drug-technology-assessment-processes-health-technology-assessment-and.

3. EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making

4. The Academy of Medical Sciences (2018) Next steps for using real world evidence. Summary report of a FORUM follow-up roundtable held on 24 January 2018. https://acmedsci.ac.uk/file-download/7021031.

5. CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3